Ceribell (CBLL) Non-Current Receivables (2023 - 2026)
Ceribell (CBLL) reported Non-Current Receivables of $1.7 million for Q1 2026, down 0.51% on a YoY basis from $1.8 million in Q1 2025, and down 5.68% quarter-over-quarter from $1.8 million in Q4 2025.
Ceribell (CBLL) Non-Current Receivables (2023 - 2026) Analysis & Trends
Ceribell has reported Non-Current Receivables for 4 years, with the latest figure at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non-Current Receivables fell 0.51% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 0.51% YoY), and the FY2025 full-year result was $1.8 million, up 22.56% from the prior year.
- Non-Current Receivables for Q1 2026 stood at $1.7 million, down from $1.8 million in the prior quarter.
- The five-year high for Non-Current Receivables was $1.8 million in Q4 2025, with the low at $1.2 million in Q4 2023.
- Historically, Non-Current Receivables has averaged $1.6 million across 4 years, with a median of $1.7 million in 2025.
- Annual changes were most pronounced in 2025 — Non-Current Receivables surged 35.14% — and 2026, when it dropped 0.51%.
- Ceribell's Non-Current Receivables stood at $1.2 million in 2023, then grew by 21.73% to $1.5 million in 2024, then gained by 22.56% to $1.8 million in 2025, then fell by 5.68% to $1.7 million in 2026.
- The last three Non-Current Receivables figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 257.56 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Ceribell | 695.83 Mn | 554.65 Mn | 23.12 Mn | 1.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.74 Mn |
| Dec 31, 2025 | 1.85 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 1.75 Mn |
| Dec 31, 2024 | 1.51 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.24 Mn |